Dana’s practice emphasizes patent portfolio strategic planning, and preparation and prosecution of U.S., international and foreign patent applications in the life sciences, including applications focused on small molecules, pharmaceuticals, synthetic methods, molecular diversity, drug discovery, polymers, materials science, and medical devices. He frequently provides clients with due diligence assessments of U.S., international, and foreign patent portfolios in connection with technology transactions and acquisitions. Dana also regularly prepares non-infringement, invalidity and clearance patent opinions in these and other areas.
Reflecting his doctorate in organic chemistry, and his postgraduate chemistry fellowship at Harvard University, Dana has a substantial record of technical accomplishments in the life sciences.
Dana was previously Deputy Chair of Foley Hoag’s Intellectual Property Group.